Videos

In this exclusive video interview, James Del Rosso, DO, gets into the details of JAK inhibitors, explaining how they work and cutting through the hype around the treatments. 

JAK Inhibitors: Drilling Down the Details

In a video for Dermatology Times®, Mark Lebwohl, MD, details how to match patients with the right psoriasis treatment for their specific needs. 

Pairing the Right Psoriasis Drug with the Right Patient

and joined the MJH Life Sciences team in April 2021. She graduated from Kent State University in 2018 with a bachelor's degree in journalism and a minor in sociology. Linda used to work as a creative writer for 

 and was a technical writer/regulatory specialist/purchasing agent at GM Industrial before coming on to the team. She enjoys reading, traveling, and learning new perspectives. You can reach her at 

Articles

An article published in the Journal of Investigative Dermatology examined genetic, environmental triggers, immunology, pathophysiology, and precision medicine in psoriasis.  

New Frontiers in Psoriatic Disease Research

A phase 3 study evaluated apremilast as a treatment for patients with mild to moderate psoriasis.  

Efficacy and Safety of Apremilast in Plaque Psoriasis

In this video interview, Mark Lebwohl, MD, explains why topicals for inflammatory conditions are vital for treatment. 

A Deep Dive on Tapinarof

Podcasts

In this episode, we dive into the background of the “The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas.” Adam Friedman, MD, and Misty Eleryan MD, MS, describe their process to creating this new dermatologic resource. 

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

The study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.

Pregnancy outcomes vary in women with psoriatic arthritis

Mark G. Lebwohl, MD, presents on what dermatologists need to know about the newest psoriasis studies during the Fall Clinical Dermatology Conference.

What to Know: Phase 3 Findings on Promising Psoriasis Pipeline

Neal Bhatia, MD, explores steroid alternatives in his presentation at the Fall Clinical Dermatology Conference.

Nonsteroidal Topical Therapies

Armand Butera is the assistant editor for 

. He attended Fairleigh Dickinson University and graduated with a degree in communications with a concentration in journalism. Prior to graduating, Armand worked as the editor-in-chief of his college newspaper and a radio host for WFDU. He went on to work as a copywriter, freelancer, and human resources assistant before joining 

. In his spare time, he enjoys reading, writing, traveling with his companion and spinning vinyl records. Email him at 

The approval was supported by promising phase 3 data of the VOLTAIRE-X clinical trial.